$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Avatrombopag is an oral "upgrade drug" that changes the fate of "elective surgery", and the implementation of medical insurance breaks the bottleneck of liver disease treatment
2026-02-01 22:25:32
Check Details
Analysis of voclosporin manufacturer information, originator drug background and drug registration approval status
2026-02-01 22:25:32
Check Details
Comparative efficacy and indication selection analysis of dabrafenib, trametinib and ponatinib
2026-02-01 22:25:32
Check Details
Analysis of domestic launch time, sales channels and patient access of Safinamide tablets
2026-02-01 22:25:32
Check Details
Detailed instructions on the usage and dosage of Tarlatamab-Imdelltra and the clinical medication regimens for different patients.
2026-02-01 22:25:32
Check Details
Telisotuzumab-EMRELIS applicable cancer types and clinical treatment options for different patients
2026-02-01 22:25:32
Check Details
A comprehensive explanation of which cancers tovorafenib is used to treat and its clinical efficacy and indications
2026-02-01 22:25:32
Check Details
Detailed description of vorasidenib-VORANIGO manufacturer and drug background, R&D companies and qualification information
2026-02-01 22:25:32
Check Details
Where can I buy Zongatinib (Zongatinib) in China and the explanation of the formal channels for purchasing the drug?
2026-02-01 22:25:32
Check Details
Analysis of clinical effects of vosoritide, observation of efficacy in different patients, and summary of medication experience
2026-02-01 22:25:32
Check Details
Is Methylcobalamin Injection (Rozebalamin) Effective for Patients with Anxiety Disorders and Its Psychological Improvement Mechanism
2026-02-01 22:25:32
Check Details
Analysis of the latest price and reimbursement ratio of cobimetinib in 2025 after it enters medical insurance
2026-02-01 22:25:32
Check Details
1
2
...
2405
2406
2407
2408
2409
2410
2411
...
2440
2441
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Zanidatamab (Ziihera): HER2 Bispecific Antibody Plus Immunotherapy for First-Line Gastric Cancer
2
Neurokinin Receptor Antagonists: A Non-Hormonal Approach to Menopausal Hot Flashes and Sleep Disturbances
3
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
4
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
5
FDA Approves First mRNA Flu Vaccine mFLUSIVA
6
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
7
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
8
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
9
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
10
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
11
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
12
ROS and Cancer: The Potential of Natural Antioxidants